eBioMedicine in conversation with
Editors at eBioMedicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to this open access journal, this podcast covers a broad range of topics, from climate change and health to microplastics in human tissues, the microbiome-gut-brain axis and binge drinking to computational pathology in 2030, and more.
Listen on:
Episodes
Tuesday Jan 18, 2022
Tuesday Jan 18, 2022
Rachel Deer joins eBioMedicine to present a study encouraging characterization of long COVID symptoms via human phenotype ontology.Read the full article:Characterizing Long COVID: Deep Phenotype of a Complex ConditionContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Wednesday Dec 22, 2021
Wednesday Dec 22, 2021
James Zou & David Ouyang join eBioMedicine to discuss issues around deep learning and hidden clinical correlates.Continue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Tuesday Dec 14, 2021
Tuesday Dec 14, 2021
Prof Beate Kampmann, Dr Karen Keddy, and Prof Peter Ghazal discuss a new cross-journal Series in The Lancet Infectious Diseases and eBioMedicine addressing the potential for and challenge of applying big data to childhood infectious diseases in LMICs.Read the full Series:https://www.thelancet.com/series/big-data-childhood-infections-LMICs Continue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Tuesday Nov 16, 2021
Tuesday Nov 16, 2021
Dr Anthony Chirwa and Dr Ben Morton join eBioMedicine to discuss controlled infections in Streptococcus Pneumoniae and the importance of localised research.Read the full article:https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(21)00372-8/fulltextContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Wednesday Oct 27, 2021
Wednesday Oct 27, 2021
Jodi Sherman joins Julie Stacey and Liam Messin of eBioMedicine to discuss the intersection between healthcare and climate change.Continue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Wednesday Sep 22, 2021
Wednesday Sep 22, 2021
How can we ensure that research being conducted is relevant to its ultimate end-users? Grace Fox and Dr Manoj Lalu join eBioMedicine to discuss the importance of patient engagement in preclinical research.Further reading:Patient engagement in preclinical laboratory research: A scoping reviewContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Wednesday Aug 04, 2021
Wednesday Aug 04, 2021
Dr Aleix Prat on the relationship between chemotherapy effectiveness and menopause in patients with breast cancer.Further reading:https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(21)00244-9/fulltextContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Tuesday Jun 29, 2021
Tuesday Jun 29, 2021
Dr. Viviana Simon and Dr. Maria Rescigno discuss their proposal that people who have recovered from symptomatic COVID-19 may require only one dose of an mRNA vaccine.Further reading:https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(21)00194-8/fulltextContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv